An interventional study of Coronal palatal tissue and Apical palatal tissue in Peri-implant Health, Free Gingival Graft and Peri-implant Mucositis, sponsored by Kutahya Health Sciences University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Months and older. Per ClinicalTrials.gov, last updated 2026-07-28.
Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Mucositis with a site in Turkey — 4 open to participants now, 5 under way, none of them phase 3. Mucositis · Turkey.
Among the 13 studies in Mucositis with a site in Turkey, this one is one of 4 that started in 2026, is one of 8 with no phase, and was the 9th registered.
265 studies on the registry are indexed under Mucositis; 34 are open to participants now.
Browse Mucositis studies →4 of the 13 studies in Mucositis with a site in Turkey are open now. Recruiting first, the newest first:
Biruni University · Sites in Turkey
Ages 18+ · Healthy volunteers
Ege University · Sites in Turkey
Ages 6–12
Inonu University · Sites in Turkey
Ages 18–70 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 21 Mucositis studies recruiting now, 13 (62%) set no upper age limit and 7 (33%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.
This study: 18 Months and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 45 across 215 interventional studies indexed under Mucositis.
Median enrollment 43 across the 9 interventional studies, 86 across the 4 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 10 most frequent:
Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 48 are open to participants now.
Kutahya Health Sciences University has 1 study filed under Mucositis — fewer than ten, so there is no comparison to draw.
5 of the studies in Mucositis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06305000Biruni UniversityImpact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis | 2026-12-10 |
| NCT07828067Inonu UniversityShort Versus Standard Dental Implants: Clinical and Biomarker Outcomes | 2026-12-30 |
| NCT07785817Medipol UniversityEvaluation of aMMP-8 and IL-1β Levels and Marginal Bone Loss Associated With Peri-Implant Mucositis and Peri-Implantitis in Postmenopausal Women | 2027-02-01 |
| NCT07330609Kutahya Health Sciences UniversityClinical, Radiographic, and Digital Evaluation of the Effects of Autogenous Grafts on Peri-implant Mucosa | 2027-08-02 |
| NCT06955338Ege UniversityMusic and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 13 studies in Mucositis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effects of autogenous grafts harvested from different palatal regions on the peri-implant mucosa when applied during second-stage dental implant surgery.
Clinical, radiographic, and digital assessment methods will be used to investigate the early effects of these grafts on peri-implant mucosal width and thickness. In addition, peri-implant tissue health and patient-reported outcomes will be evaluated to compare the effectiveness of the grafting techniques in peri-implant soft tissue management.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive grafts including marginal and interdental palatal gingiva.
Procedure: Coronal palatal tissue
Participants in this group will receive grafts harvested from approximately 1.5 mm apical to the palatal gingival margin.
Procedure: Apical palatal tissue
This group will receive palatal grafts including marginal and interdental gingiva. This coronal palatal tissue will be applied to the peri-implant tissue at the second-stage implant surgery.
This group will receive palatal grafts harvested from approximately 1.5 mm apical to the gingival margin. This graft will be applied to the peri-implant tissue at the second-stage implant surgery.
Peri-implant Mucosal Thickness
The primary outcome is the change in peri-implant mucosal thickness measured at four time points using clinical and digital methods.
Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)
Keratinized Mucosa Width
Keratinized tissue width will be measured from the mid-buccal aspect of the edentulous area.
Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)
Vestibular Depth
Vestibular depth is defined as the vertical distance between the midcrestal area and the point of greatest concavity of the mucosal fold.
Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)
Modified Plaque Index
Modified plaque index will be measured at six points around each implant by an index with a minimum value of 0 and a maximum of 3.
Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading
Modified Bleeding Index
Modified bleeding index will be measured at six points around each implant by an index with a minimum value of 0 and a maximum of 3.
Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading
Peri- implant Probing Depth
Peri-implant probing depth will be measured at six points around each implant.
Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading
Mucosal Recession
Mucosal recession will be measured as the distance between the implant abutment interface and the mucosal margin.
Time frame: 12th month after prosthetic loading
Marginal Bone Level
Marginal bone level will be measured on periapical radiographs taken by the parallel technique.
Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)
Pink Esthetic Score (PES)
Peri-implant soft tissue esthetics will be evaluated using the Pink Esthetic Score with a minimum value of 0 and a maximum of 14.
Time frame: Postoperative 3rd month (second-stage implant surgery) and 12th month after prosthetic loading
Postoperative Pain Assessment
Postoperative pain as patient-reported outcome will be recorded using a visual analog scale (VAS; 0-100).
Time frame: Postoperative 14 days (daily after graft application)
Analgesic Consumption
The amount of analgesic medication used (mg) will be recorded.
Time frame: Postoperative 14.days (after graft application)
Patient Satisfaction
Patient satisfaction with the surgical procedure will be assessed using a three-point Likert scale (0 = no, 1 = maybe, 2 = yes).
Time frame: Postoperative 14.days (after graft application)
Patient-Perceived Esthetic Outcome
Patient perception of peri-implant soft tissue esthetics will be evaluated using a visual analog scale (VAS; 0-100).
Time frame: 12th month after prosthetic loading
Oral Health-Related Quality of Life
Oral health-related quality of life will be assessed using the Oral Health Impact Profile (OHIP-14) questionnaire.
Time frame: Postoperative 3rd month (second-stage implant surgery) and 12th month after prosthetic loading
Plan to share: No
Started Feb 2026 (actual). Primary completion is estimated for Aug 2027, 18 months after the start.
Of 67 non-industry interventional studies with no phase under Mucositis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 26. This study's planned 18 months is above that.
Counting every sponsor, half of 70 studies reached it within 12 months; a quarter within 6 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University →